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Abstract
Background: To gain insight into potential roles of isomiR spectrum and isomiRs with 39 additions in pre-eclampsia, we
performed a comprehensive survey of miRNA repertoire and 39 addition events from placental samples with different
degrees of pre-eclampsia by applying SOLiD sequencing platform.
Principal Findings: Over 30% isomiRs were detected with 39 non-template additional nucleotides, especially for additional
nucleotide of adenosine. However, these modified isomiRs showed a lower percentage of total miRNA expression (,15%).
Generally, 1-3 abundant isomiRs from a given miRNA locus were identified, but none of them was detected with 39
additions. Different miRNAs indicated various isomiR spectrums and expression patterns. The most abundant isomiR
spectrum, isomiR profile and expression pattern always were stability, but herein we found several exceptions across
samples, especially between normal and diseased samples. At isomiR level, we detected a distinct subset of differentially
expressed modified isomiRs between normal and diseased samples or between mild and severe samples. Gene Ontology
analysis of their experimentally validated target genes revealed enrichment for specific biological process categories.
Conclusions: The phenomenon of multiple isomiRs, especially for isomiRs with 39 additions, is not a random event during
pre-miRNA processing. Varieties of isomiRs and expression patterns reveal potential functional implication and should be
taken into account. The study enriches association of miRNAs and human disease, including potential roles of various
miRNA variants and 39 addition events.
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Introduction
MicroRNAs (miRNAs), a class of endogenous small non-coding
RNAs (,22 nt), play pivotal post-transcriptional regulatory roles
in normal physiological functions by targeting messenger RNAs
for cleavage or translational repression [1,2,3]. It is believed that
miRNA contributes to regulatory network by complementary
binding of its ‘‘seed sequence’’ (nucleotides 2–8) and targets in
the 39 untranslated region of mRNAs [4]. Altered expression of
specific miRNAs has been reported to associate with a number of
diseases, including various human cancers. Entire repertoires
of miRNAs in normal and cancer tissues are performed to assess a
subset of differentially expressed miRNA species and discover
potential diagnostic miRNA biomarker. The small non-coding
RNA is generated from a ,70 nt miRNA precursor hairpin (pre-
miRNA) that is resulted from a ,1–3 kb primary miRNA
transcript [5,6]. Typical miRNA biogenesis shows that miRNA
precursor produces active miRNA and inactive miRNA* sequenc-
es. miRNA, known as ‘‘mature miRNA’’, is loaded into AGO to
contribute regulatory network, whereas miRNA*, also termed as a
passenger strand, is long thought to be degraded and discarded
[7]. But recent evidence indicates that miRNA* can also be loaded
into AGO2 and bind target mRNAs to play a role in regulation
network as a potential regulatory molecule [8,9,10,11,12,13].
High-throughput sequencing technologies are offering a broad
and deep survey of the interesting and pivotal small non-coding
regulatory molecules. Discovering and profiling of miRNAs have
been widely studied in animals and plants, especially for various
human diseases. Based on high-sensitivity and high-throughput
sequencing datasets, more small RNAs are detected, including
multiple miRNA variants (isomiRs) [14,15,16,17,18] and micro-
RNA-offset RNAs (moRNAs) [19,20,21]. Multiple isomiRs with
various 59 and/or 39 ends are thought to be the result of inexact
Drosha and Dicer processing. These small RNAs have greatly
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network. Moreover, the phenomenon of 39 addition events,
especially for post-transcriptional non-template 39 end additions of
adenosines or uridines, is widely detected in animals and plants
[4,14,17,22,23,24,25,26,27,28,29,30]. In animals, these terminal
nucleotides are added after Dicer processing [31], and most 39
additions are added to canonical miRNA sequences (reference
miRNA sequences in the miRBase database) [24]. The phenom-
enon is not a random event, but is widespread and conserved
across animal species [23]. Further, 39 additions may contribute to
miRNA stability and play a role in interactions of miRNA:target
[23,24]. Multiple isomiRs with heterogeneous ends and non-
template nucleotide additions are differentially expressed across
different development and tissues in Drosophila melanogaster [24]. 39
addition events show potential biological function in complex
regulation network. For example, isomiRs with 39 additions may
increase miRNA stability in Drosophila [24], may be differentially
loaded into Argonautes [4,14], may attenuate the effectiveness of
specific miRNAs [23], and isomiRs with adenosines are less prone
to degradation in P. trichocarpa [28]. However, little is known about
whether there is a potential relationship between multiple isomiRs
and human disease.
Pre-eclampsia is a relatively common human disease of
pregnancy characterized by hypertension and proteinuria. It
originates in the placenta and causes some maternal and fetal
problems, and even might threaten maternal and perinatal
survival. Abundantly and differentially expressed miRNA species
in placental samples were reported by applying microarray
analysis and real-time quantitative reverse transcription-ploymer-
ase chain reaction [32,33,34,35,36,37,38,39], but little is known
about isomiR profile and potential association with different
degrees of human pre-eclampsia. In the study, to test whether
multiple isomiRs and 39 addition events are biologically regulated
and show close relationship with different degrees of pre-
eclampsia, we deep-sequenced small RNA libraries by applying
the next generation high-throughput sequencing platform, SOLiD
System (ABI, Life Technologies). Based on a comprehensive
analysis, multiple miRNA variants and miRNAs with 39
modifications were identified and profiled across placental
samples. Simultaneously, due to multiple isomiRs from a given
locus with various expression levels, we therefore assessed miRNA
profile by employing the most abundant isomiR and sum of all
isomiRs, respectively. Differentially expressed miRNAs and
isomiRs with 39 additions were surveyed and further studied
across different samples.
Results
A widespread phenomenon of 39 addition events
Using the next generation sequencing technology, SOLiD
System, we sequenced the small RNAs of placental samples from
pregnant women with mild and severe pre-eclampsia and normal
pregnant woman (Table S1). According to short RNAs that could
be mapped to human miRNA precursors, the most abundant
length was 22 nt, as expected (Figure S1). Although similar length
distribution patterns were detected across the three samples,
different percentages could be found, especially between normal
and diseased samples (Figure S1). miRNAs with 39 non-template
additional nucleotides were widely detected in the three samples,
and adenosine was the most abundant and prevalent additional
nucleotide (Figure 1). Over 30% isomiRs were found to have 39
additions (Figure 1A). Although there was much larger percentage
based on type of isomiRs, these modified isomiRs showed lower
percentage of total expression level (lower than 15%, Figure 1B).
Compared with diseased samples, isomiRs with 39 additions in
normal sample showed higher percentage of total miRNA
expression (about 14.74%). Over 15% total isomiR types were
characterized by 39 additional of adenosine (Figure 1C and
Figure 1D). Additional cytosine was more prevalent in normal
control sample than diseased samples (Figure 1C–F). Rare 39
additional guanine was detected in the three samples.
IsomiRs with 39 non-template additional nucleotides may have
shorter, longer or consensus lengths with their canonical miRNA
sequences. For example, modified isomiRs of hsa-miR-24 showed
various length distributions, and additional nucleotide could be
added 39 end of canonical miRNA sequence, shorter or longer
isomiRs (Figure 2). Although some isomiRs with 39 additions also
had higher sequence counts, they were not abundant isomiR
species in the miRNA locus (Figure 2).
The top 10 abundant miRNA species and modified
isomiR species
According to the sequence count of the most abundant isomiR
from a single miRNA locus, we assessed the top 10 abundant
miRNA species (Table 1). Hsa-miR-24 was the most abundant
miRNA, while only 3 miRNAs were shared by the three samples
(Table 1 and Figure 3A). There were 7 common miRNAs between
mild and severe samples, but they showed different order
distributions (Table 1). Simultaneously, we also reassessed the
top 10 abundant miRNA species according to sum of all isomiRs.
Similar to Guo & Lu (2010) [40], the inconsistent order
distribution was shown based on different estimation methods
(Table 1). We therefore obtained another subset of the top 10
abundant miRNA species based on sum of all isomiRs, as expected
(Figure 3B). Similar distribution patterns were detected based on
different estimation methods despite involved different miRNA
species (Figure 3A and Figure 3B). Mild and severe samples shared
more common miRNAs than between normal control and
diseased samples (Figure 3A and Figure 3B).
The top 10 most abundant isomiR species with 39 additions
showed that some of them were yielded from the same miRNA
locus (Table 2). For example, several of them were modified
isomiRs of hsa-miR-24 (Table 2 and Figure 2A). We found many
abundant modified isomiRs had the same lengths with their
canonical miRNA sequences, which indicated 39 non-template
nucleotides were added to the 39 ends of shorter isomiR sequences
than canonical sequences (Table 2 and Figure 2). It is inconsistent
with a previous report that isomiRs with 39 additions always were
longer than canonical miRNA sequences [24]. Indeed, the shorter
isomiR always also showed higher expression level, and even was
the most abundant isomiR (for example, the length of the most
abundant hsa-miR-145 in normal sample was shorter than its
canonical length). The particular phenomenon was more preva-
lent in diseased samples than normal sample (Table 2). Compared
with the top 10 abundant miRNA species, perhaps due to diversity
of isomiR species with 39 additions, less common isomiRs were
detected across the three samples (Figure 3). We only found one
common isomiR among normal and diseased samples (hsa-miR-
24–65-A, ‘‘65’’ indicated the end site on hsa-mir-24-1). There
were 3 common isomiRs between normal and mild samples, while
only hsa-miR-103-U was shared by normal and severe samples
(Figure 3C).
Differentially expressed miRNAs and modified isomiRs
Different estimation schemes were used to assess differentially
expressed miRNAs across different samples. According to sequence
count of the most abundant isomiR, fold change values of 15
miRNAs were over 4 or less than -4 between at least one pair of
miRNA Repertoire and 39 Addition in Pre-Eclampsia
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between normal and diseased samples, and 5 of them were detected
between mild and severe pre-eclampsia samples (Figure 4A). The
same miRNA species could be detected if sum of all isomiR
sequence counts were used to assess expression profiles (Figure 4A
and Figure 4B). However, fold change values might be slightly
changed based on different estimation methods. For example,
log2(severe/normal) of hsa-miR-143 was 25.29 (based on the most
abundant isomiR) and 25.69 (based on sum of all isomiRs),
respectively.
Meanwhile, at isomiR level, we also estimated differentially
expressed isomiRs with 39 additions. A total of 40 abundant
modified isomiRs were analyzed, and 15 of them were differentially
expressed at least between one pair of samples (Figure 4C).
Similarly, many of these isomiRs were detected between normal
and diseased samples, and only 5 of them were detected between
mild and severe samples (hsa-miR-143-U, 29a-A, 30d-A, 518e-A
and 520g-A). Among these differentially expressed modified
isomiRs, seven of them were consistent with differentially expressed
miRNA species (Figure 4). Overall, most of these abundant 39
Figure 1. Percentage distributions of isomiRs with 39 additions. IsomiRs are estimated if their sequence counts are not less than 10.
Percentage of 39 additions based on (A) type of isomiRs; (B) sequence counts of all isomiRs; (C) type of all isomiRs; (D) sequence counts of all isomiRs;
(E) type of isomiRs with 39 additions; (F) sequence counts of isomiRs with 39 additions.
doi:10.1371/journal.pone.0021072.g001
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PLoS ONE | www.plosone.org 3 June 2011 | Volume 6 | Issue 6 | e21072Figure 2. Detailed isomiRs, their length distributions and relative expression levels. Hsa-miR-24 is the most abundant miRNA in the three
samples. (A) Detailed isomiRs and their sequence counts across samples. Sequence in pink box is canonical hsa-miR-24 sequence in the miRBase
database. 39 additions are highlighted by using lowercase letters in different colors. IsomiRs are not presented here if they have lower sequence
counts than 100 in mild and sever samples. The signal of ‘‘—’’ shows sequence count of the isomiR is lower than 5 or not detected in normal sample.
(B) Length distribution of isomiRs based on their sequence counts. As expected, the most dominant length is 22 nt. (C) Relative expression levels of
isomiRs are estimated based on percentage of all isomiRs of hsa-miR-24. These isomiRs are showed according to start and end sites on hsa-mir-24-1
sequence. Evident differences can be detected of isomiRs with locations of 44–61, 44–63-A, 44–63 and 44–65-A.
doi:10.1371/journal.pone.0021072.g002
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detected (Figure 4C). Interestingly, except for isomiR of hsa-miR-
520 g, other isomiRs with 39 additions had the same 59 ends and
‘‘seed sequences’’ with their canonical miRNA sequences in the
miRBase database. Thus, we collected their experimentally
validated targets sites from the miRTarBase database (Table S2).
Gene Ontology analysis of these experimentally validated target
genes revealed enrichment for specific biological process categories,
for example, regulation of transcription, apoptosis, cell cycle,
immune response, response to stimulus, etc.
Varieties of isomiR spectrums and expression patterns
Multiple isomiRs with various 59 and/or 39 ends and expression
levels, including isomiRs with 39 additions, were detected from a
given miRNA locus (Figure 2 and Figure 5). Despite involved
various 59 and/or 39 ends due to imprecise cleavage of Drosha and
Dicer, variation at 39 ends was more prevalent than 59 ends
(Figure S2). Generally, 59 ends were more conserved than 39 ends,
which ensured stability of their ‘‘seed sequences’’ (nucleotides 2-8).
Different miRNAs showed different numbers of miRNA variants
with various expression levels. For example, in mild sample, miR-
451 was found 10 variants (sequence counts of them were over 99),
while miR-130a was only found 2 variants (Figure 5 and Figure 6).
Although expression levels of the two miRNAs were similar, their
isomiR types and expression patterns showed a distinct difference.
Moderate correlation was reported between expression level of
miRNA and type of isomiRs [15], but unexpectedly, we herein
found some exceptions: miR-519a was found fewer type of
isomiRs although it had higher expression levels than miR-451
(Figure 6). To obtain more detailed correlation between expression
level of miRNA and type of isomiRs, we performed a com-
prehensive analysis according to abundant miRNA species by
employing the most abundant isomiR and sum of all isomiRs,
respectively. No strict correlation was detected, especially based on
the most abundant isomiR (Figure 7, Figure S3 and Table S3).
Interestingly, some miRNAs showed inconsistent the most
abundant isomiR spectrums (for example, hsa-miR-145, 451, 515
and 519d) across the different samples, especially between normal
and diseased samples (Table S4). Despite of the difference in
sequences, these isomiRs were 39 isomiRs with the same 59 ends.
They may be canonical miRNA sequences or inconsistent
sequences. In order to further understand isomiR spectrum, we
also estimated fold change of the most and secondary abundant
isomiRs. Except for hsa-miR-519d, fold changes always were less
than 2, which suggested several abundant isomiRs with similar
expression levels from a given miRNA locus (Table S4). Indeed,
the phenomenon of various expression differences could be
detected according to more miRNAs: the most abundant isomiR
of miR-130a was over 29.60-fold than the secondary abundant
isomiR (Figure 6A), while similar expression levels (over 1.17-fold)
could be found between the most and secondary abundant
isomiRs of miR-451 (Figure 6D). According to expression
distributions of multiple isomiRs and fold change values of the
most and secondary abundant isomiRs, we also estimated
Figure 3. Distribution of abundantly expressed miRNAs across
samples. The top 10 abundant miRNA species are estimated based on
(A) the most abundant isomiR and (B) sum of all isomiRs. The top 10
abundant isomiR species with 39 additions are also estimated (C).
doi:10.1371/journal.pone.0021072.g003
Table 1. The top 10 most abundant miRNA species in the
three samples.
No. Normal Mild Severe
The
most
All
isomiRs
The
most
All
isomiRs
The
most
All
isomiRs
1 miR-24 miR-24 miR-24 miR-24 miR-24 miR-24
2 miR-521 miR-515 miR-517a miR-517a miR-517a miR-517a
3 miR-29b miR-145 miR-519a miR-519d miR-519d miR-519d
4 miR-103 miR-143 miR-519d miR-519a miR-519a miR-519a
5 miR-515 miR-424 miR-517c miR-23a miR-103 miR-23a
6 miR-424 miR-521 miR-521 miR-451 miR-29a miR-103
7 miR-143 miR-29b miR-23a miR-520g miR-130a miR-29a
8 miR-145 miR-103 miR-103 miR-517c miR-517c miR-517c
9 miR-23a miR-23a miR-520g miR-521 miR-23a miR-130a
10 miR-29c miR-29c miR-451 miR-103 miR-29c miR-29c
The top 10 most abundant miRNA species are estimated based on the most
abundant isomiR (The most) and sum of all isomiRs (All isomiRs), respectively.
doi:10.1371/journal.pone.0021072.t001
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processing (Figure 6). Dominant cleavages sites always were
concentrated on some specific sites (1–3 continuous sites) (Figure 6).
Although multiple isomiRs with various 59 and/or 39 ends from
a given locus were identified, they showed various expression
levels. Generally, 1–3 isomiRs were abundantly expressed,
whereas others always had fewer sequence counts (Figure 5).
Strikingly, although some isomiRs with 39 non-template nucleo-
tides had higher sequence counts, they only showed a very low
percentage of total expression from the given locus (Figure 2 and
Figure 5). The abundant isomiRs were canonical miRNA
sequence or inconsistent sequences without 39 additions. Similar
expression distributions could be detected across the three
samples, especially some of them indicated consensus distributions
(for example, hsa-miR-519a and hsa-miR-521). Based on a single
miRNA, relative expression level of specific isomiR might be
different, especially between normal and diseased samples. For
example, although similar expression distributions of isomiRs of
hsa-miR-517c were detected, specific isomiR showed different
percentage of total expression (Figure 5).
Discussion
Non-random isomiR spectrum reveals biological
implication
Due to high-sensitivity of high-throughput sequencing technol-
ogies, multiple miRNA variants with heterogeneous ends, lengths
and expression levels, termed as isomiRs, were widely detected in
animals and plants [14,15,16,17,18]. Although abundantly ex-
pressed miRNA has the potential to generate more type of isomiRs,
and type of isomiRs shows a moderate correlation with expression
level of corresponding miRNA [15], we herein found that there was
no strict connection between them (Figure 6, Figure 7, Figure S3
and Table S3). Expression level of miRNA sometimes was not a
critical factor in generating type of isomiRs (Figure 6). This
phenomenon indicated complexity during processing of pre-
miRNAs (Figure 7, Figure S3 and Table S3). Type of isomiRs
from a given locus, particularly for those abundant isomiRs, always
was conserved across different samples, but they also showed
flexibility due to involved differences of total sequencing reads
(Figure 5, Table S1 and Table S3). Despite more or less type of
isomiRs was detected, significant expression differences were easily
detected. Generally, every miRNA locus yielded 1–3 abundant
isomiRs and other rare isomiRs (Figure 2, Figure 5 and Figure 6).
Therefore, expression differences of isomiRs led to various fold
changes of the most and secondary abundant isomiRs. Dominant
cleavage sites of Drosha and Dicer were estimated based on the fold
changes, and distinct differences among different miRNAs were
found (Figure 6). The dominant cleavage sites always were
concentrated on some specific regions (1–3 continuous sites), and
therefore generated several abundant isomiRs (Figure 6). These
abundant isomiRs always were 39 isomiRs with the same 59 ends
and ‘‘seed sequences’’, but none of them was detected with 39 non-
template additional nucleotides. The interesting dominant cleavage
ensured consistent target sites.
More importantly, we found bias of the degree of heterogeneity
between 59 and 39 ends based on a comprehensive analysis without
involved isomiRs with 39 additions (Figure S2). 39 isomiRs with
various 39 ends were more prevalent than 59 isomiRs, and
abundantly expressed isomiRs always were 39 isomiRs. It is well
known that miRNAs will involve new identities (seed sequences,
nucleotides 2–8) if their 59 ends are changed or shifted. The
interesting expression bias may implicate functional selection:
identities of 39 isomiRs were not changed and ensured the same
‘‘seed sequences’’ to bind target mRNAs and regulate biological
processes. On the other hand, 39 addition events further enriched
dominant 39 isomiRs (Figure 1, Figure 2 and Figure 5). Some
enzymeshave beenassociated with the 39 addition events inanimals
[23,31,41,42], and adenosine was the most dominant and abundant
additional nucleotide (Figure 1, Figure 2 and Figure 5) [23,24].
Multiple isomiRs with end heterogeneity were not caused by RNA
degradation during sample preparation steps [26], and were the
final result of strict regulationduringpre-miRNA processing. Taken
together, these findings revealed isomiR spectrum should not be a
random event due to imprecise and alternative cleavages of Drosha
and Dicer during pre-miRNA processing, which might provide
potential implication for biological processes, especially for
complexity of isomiRs with 39 non-template additional nucleotides.
Therefore,we further performed global analysis of isomiR spectrum
and expression distribution across normal and diseased samples.
Different miRNAs showed different type of isomiRs with various
expression levels (Figure 5 and Figure 6). Relative expression levels
of isomiRs from a given locus showed consistent or inconsistent
distribution patterns across samples (Figure 5). Inconsistent
Table 2. The top 10 most abundant isomiR species with 39 additions in the three samples.
No. Normal Mild Severe
miR-addition Start-end (ref) miR-addition Start-end (ref) miR-addition Start-end (ref)
1 miR-24-A 44–63 (44–65) miR-24-A 44-65 miR-24-A 44–65
2 miR-143-U 61–82 (61–81) miR-24-U 44–66 (44–65) miR-24-U 44–66 (44–65)
3 miR-424-A 11–33 (11–32) miR-519d-A 54–76 (54–75) miR-519d-A 54–76 (54–75)
4 miR-145-A 16–36 (16–38) miR-517a-A 54–75 miR-24-A 44–66 (44–65)
5 miR-515-U 51–74 (51–72) miR-518e-A 54–75 (54–74) miR-517a-A 54–75
6 miR-103-U 48–70 miR-24-A 44–63 (44–65) miR-517a-C 54–75
7 miR-515-U 51–73 (51–72) miR-24-U 44–65 miR-518c-A 62–84
8 miR-24-A 44–65 miR-517a-C 54–75 miR-103-U 48–70
9 miR-199a-A 47–69 (47–68) miR-145-A 16–36 (16–38) miR-29a-A 42–64 (42–63)
10 miR-521-A 54–75 miR-521-A 54–75 miR-519d-C 54–76 (54–75)
‘‘Start-end (ref)’’ shows start-end sites on corresponding precursor including 39 non-template nucleotide, and ‘‘ref’’ shows reference start-end sites on the precursor in
the miRBase database. Empty ‘‘ref’’ shows consistent location. If specific miRNA has multicopy precursors, we here default the first miRNA precursor.
doi:10.1371/journal.pone.0021072.t002
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diseased samples, may indicate potential function and contribute to
complex regulatory network. For example, isomiRs of hsa-miR-143
in severe sample showed different expression pattern with normal
and mild samples, while isomiRs of hsa-miR-103 and hsa-miR-424
in normal sample showed inconsistent expression patterns with
diseased samples (Figure 5). These miRNAs played a role in
regulating important biological processes, such as cell growth and
apoptosis,transcriptionaccordingtoexperimentallyvalidatedtarget
genes. Differentially expression pattern of isomiRs from a given
locus may implicate potential regulation contribution, although we
still have not experimental evidence. On the other hand, the most
abundant isomiR spectrum might be different across normal and
diseased samples despite these isomiRs were 39 isomiRs and had the
same ‘‘seed sequences’’ (Figure 5 and Table S4). Indeed, the most
abundant isomiR maybe differentamong different species and even
Figure 4. Differentially expressed miRNAs and modified isomiRs across samples. Fold change of miRNA expression of pairwise samples is
estimated (A) sequence count of the most abundant isomiR (.999 at least in one sample), (B) based on sum of all isomiR sequence counts (.999 at
least in one sample) and (C) isomiR with 39 addition (.300 at least in one sample), respectively. If fold change value is more than 4 or lower than -4,
the differentially expressed miRNA will be marked. If some miRNAs are not detected or their sequence counts are less than 100, 10 will be their
default sequence counts.
doi:10.1371/journal.pone.0021072.g004
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found the dominant isomiR varies in placental samples with normal
control and different degrees of pre-eclampsia (Table S4). For
example, hsa-miR-519d showed two different dominant sequences
in normal and diseased samples, and they were inconsistent with
canonical hsa-miR-519d. Nonetheless, these dominant sequences
had the same 59 ends and ‘‘seed sequences’’ with the canonical
sequence, and only lengths and 39 ends were changed (Table S4). It
is uncertain that difference of 39 ends and lengths might play a role
in development of pre-eclampsia or be associated with activity of
miRNAs. Further studies, especially experimental studies, should
reveal whether 39 ends and lengths influence activity of miRNAs, as
well as to elucidate potential mechanisms of miRNAs with 39
additions during regulating biological processes.
Overall, multiple isomiRs should not be a random result due to
imprecise and alternative cleavage of Drosha and Dicer during
pre-miRNA processing. The variety of isomiRs may play a role in
regulating biological processes and reveal potential biological
implication. The major reasons are as follows. (1) Type of isomiRs
may be different across different miRNAs, and no strict correlation
was detected between type of isomiRs and expression level of
miRNA; (2) Most isomiRs were 39 isomiRs with 39 variations due
to bias of cleavage, and these 39 isomiRs always ensured the same
identities with their canonical miRNAs; (3) Generally, 1–3
abundant isomiRs were identified from a given locus, but number
of abundant isomiRs and dominant cleavage sites showed diversity
across different miRNAs. Abundant isomiRs always were 39
isomiRs and had the same 59 ends and ‘‘seed sequences’’, but none
of them was detected with 39 non-template additional nucleotides;
(4) 39 addition event was a widespread phenomenon. Additional
nucleotide showed a strong bias towards adenosine. Modified
isomiR also could be abundantly expressed despite it was not
characterized as abundant isomiR from a specific miRNA locus;
(5) The most abundant spectrum may be different in the same
tissues from normal and diseased samples, even from samples with
different degrees of disease. Despite different sequences were
detected, they were 39 isomiRs and had the same identities; and (6)
IsomiR spectrums and their expression distributions always were
stability, and their alternation may influence specific biological
processes, even may contribute partly to pathogenesis of disease.
Consistent differential expression profiles based on
different estimation methods
xmiRNAs always showed 1–3 abundant isomiRs and other rare
isomiRs, and expression levels of miRNAs might show different
distribution patterns based on estimation methods of the most
abundant isomiR and sum of all isomiRs, respectively [40]. In the
study, we collected the top 10 abundant miRNA species based on
the most abundant isomiR, but they showed inconsistent distribu-
tionsaccordingtoestimationmethodofsumofallisomiRs(Table1).
Due to varieties of type and expression levels of isomiRs, especially
number of abundant isomiRs, expression distributions indicated
different patterns according to different estimation methods. As
expected, the top 10 abundant miRNAs showed different miRNA
species and distributions (Figure 3A and Figure 3B).
Based on the inconsistent distributions, we then asked whether
there were inconsistent differential expression profiles based on
different estimation methods across samples. Here, despite de-
tailed fold change values were different, consistent differentially
expressed miRNAs were collected (default fold change values were
more than 4 or lower than 24) across samples according to the
most abundant isomiR and sum of all isomiRs, respectively
(Figure 4A and Figure 4B). The consistent differential expression
profiles were mainly resulted from conservation of isomiR
spectrum across different samples, although different expression
patterns were detected. In fact, isomiR spectrum was also
conserved across different species [26]. Therefore, consistent
differentially expressed miRNA profiles would be obtained based
on either sequence count of the most abundant isomiR or sum of
all isomiR sequence counts. Additionally, experimental miRNA
research is prone to detect abundant isomiRs, particularly
involved complexity of isomiRs with 39 additions, perhaps the
most abundant isomiR looks like a practical marker to profile
miRNAs. Simultaneously, miRNA with 39 addition, actual specific
isomiR with 39 non-template additional nucleotide, was not
abundant isomiR from the specific miRNA locus. These modified
miRNAs have potential function to influence miRNA stability and
play a role in interactions of miRNA:target [23,24]. Therefore, in
the study, at isomiR level, we also assessed differentially expressed
isomiRs with 39 additions based on their sequence counts
(discussed later).
Potential critical roles of isomiRs with 39 additions
Increasing evidence has demonstrated that miRNAs are subject
to 39 nucleotide additions, especially post-transcriptional non-
template 39 additions of adenosines or uridines [4,14,17,22,23,24,
25,26,27,28,29,30]. Here, we attempted to find potential relation-
ship between modified isomiRs and human disease by performing
a comprehensive analysis based on high-throughput sequencing
datasets. Over 30% isomiRs were detected with 39 additions, while
they showed lower (,15%) expression percentage (Figure 1A and
Figure 1B). Similar to recent studies [23,24], adenosine was the
most abundant and prevalent 39 additional nucleotide (Figure 1
C–F). Although many isomiRs were detected the phenomenon of
39 addition events, they always showed lower expression levels
(percentage was less than 17%) and were not abundant isomiRs
(Figure 2 and Figure 5). According to the fact that many isomiRs
were characterized as modified isomiRs but showed lower
expression levels (,15%), negative or ambiguous 39 additions
from errors introduced during small RNA library preparation
contribute partly to the widespread phenomenon. Indeed, we also
assessed the 39 addition events based on abundant isomiRs
(sequence counts .99), and we found only about 20% of total
isomiRs were detected the phenomenon (Figure S4). Generally,
these modified isomiRs had lower percentage of total expression
from a given miRNA locus, although other isomiRs from the same
locus were highly expressed (for example hsa-miR-24, Figure 2
and Figure 5). However, some of these modified isomiRs also were
unexpectedly quite abundant, which suggests a potential role in
regulatory network. 39 addition events play a role in modulating
miRNA effectiveness and stability or strengthen miRNA:target
interactions [23,24]. We then asked whether it also contributes to
pathogenesis of human disease. Systematic analysis showed that
isomiRs with 39 additions in normal sample was more prevalent
Figure 5. Various of type of isomiRs and their expression patterns across samples. The ordinate axis indicates percentage expression, and
the horizontal axis indicates type of isomiRs from a given miRNA locus. If modified isomiR shows over 5% expression percentage or had higher
sequence count (.999 in at least one sample), it is highlighted in the horizontal axis using the additional nucleotide. Blue line indicates isomiRs in
normal sample; red line indicates isomiRs in mild sample; green line indicates isomiRs in severe sample. Relative expression levels are estimated based
on percentage of sequence counts. All of these miRNAs are identified as the top 10 abundant miRNAs at least in one sample.
doi:10.1371/journal.pone.0021072.g005
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miRNA level, modified isomiRs showed more private isomiRs
based on the top 10 abundant species, and some of them were
derived from the same miRNA locus (Figure 3). Many modified
isomiRs were abundantly expressed and had higher expression
levels, although they showed lower relative percentage of total
Figure 6. Multiple isomiRs through alternative and imprecise cleavage. Part of miRNA precursor, multiple isomiRs (sequence counts .99)
with their sequence counts and second structure of pre-miRNA with dominant cleavage sites are presented here. Sequence in red background is the
most abundant isomiR, while sequence in blue is the secondary abundant isomiR. 39 non-template nucleotides are highlighted by using lowercase in
black body. Inferred dominant cleavage sites of Drosha and Dicer are indicated in grey and dark arrows, respectively. If the fold of the most and the
secondary abundant is less than 5, non-dominant cleavage sites are indicated using small arrows.
doi:10.1371/journal.pone.0021072.g006
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locus. These findings revealed potential role of 39 addition events
in pathogenesis of pre-eclampsia.
Generally, isomiRs with 39 additions were not abundant
isomiR species from a given locus, although in some cases they
also showed higher sequence counts (Figure 2 and Figure 5). The
non-template 39 additional nucleotides are added after Dicer
processing in animals [24,31], and these additional nucleotides
are added to 39 ends of miRNAs that might be canonical
miRNAs, shorter or longer miRNAs (Figure 2). The additional
nucleotide selection is not random. For example, hsa-miR-24 had
several modified isomiRs, but adenosines and uridines were
dominant additional nucleotides (Figure 2A). These results
revealed that non-random addition event might play critical role
in miRNA regulatory network. In fact, we found a distinct subset
of differentially expressed modified isomiRs, especially for
isomiRs with 39 adenosines (Figure 4C). Interestingly, these
isomiRs might not be derived from differentially expressed
Figure 7. Distribution patterns of miRNAs and type of isomiRs. Expression distribution of miRNAs is assessed from lower to higher expression
levels based on the most abundant isomiR, while their corresponding types of isomiRs show chaos distributions. All of these miRNAs are abundantly
expressed in corresponding sample (sequence count of the most abundant isomiR is over 999). Type of isomiRs is assessed based on their sequence
counts (.99).
doi:10.1371/journal.pone.0021072.g007
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their canonical miRNAs. Therefore, we subsequently collected
experimentally validated miRNA-target interactions of these
miRNAs from the miRTarBase database [43], and further Gene
Ontology analysis revealed enrichment for specific biological
process categories, including regulation of transcription, apopto-
sis, cell cycle, immune response, response to stimulus, etc.
Furthermore, some double-nucleotide unambiguous 39 non-
template additions, including AA and UU additions, were
observed in literature [23]. Here we also found the interesting
double additional nucleotides, especially for dominant AA, AU
and GA (Figure S5). Similarly, expression difference could be
detected among samples, especially between normal and diseased
samples (Figure S5). As an important post-transcriptional
processing event, isomiRs with 39 additions may play a role in
attenuating effectiveness of specific miRNA by interfering with
incorporation into RISC (the RNA-induced silencing complex),
similar to ‘‘miRNA assassins’’ [23,44].
Taken together, isomiRs with 39 non-template additional
nucleotides may be involved in pathogenesis of human disease.
The phenomenon of 39 addition events may influence miRNA
stability and play a role in interactions of miRNA:target [23,24],
and we therefore believe further studies will provide more
detailed potential relationship between these abundant modified
isomiRs and human diseases. Specific isomiR with 39 additional
nucleotide will be a new marker to discover mechanism of human
diseases.
Materials and Methods
Small RNA library preparation and sequencing
Placental samples of pregnant women were obtained from
Zhongda Hospital, Nanjing, China. The institutional review
board at Zhongda Hospital approved the tissue acquisition
protocol to conduct the study. Written informed consent was
obtained from each participant before tissue acquisition. Of these
samples, one of them was from normal control pregnant woman,
and others were from pregnant women diagnosed as mild and
severe pre-eclampsia, respectively. Total RNAs of these samples
were extracted with TRIzol (Invitrogen). Small RNAs were
isolated from their total RNAs using mirVana
TM miRNA
Isolation Kit (Ambion). According to the protocol of SOLiD
TM
Small RNA Expression Kit (Life Technologies), purified small
RNAs were subjected to miRNA library construction. Sequenc-
ing was carried out using SOLiD
TM sequencing platform (ABI,
Life Technologies) at the State Key Laboratory of Bioelectronics,
School of Biological Science and Medical Engineering, Southeast
University, China.
Small RNA analysis
Sequencing files in colorspace were collected from SOLiD
System based on a two-base encoding technology. According to
SOLiD miRNA analysis pipeline (http://SOLiDsoftwaretools.
com/gf/project/srna/), human other non-coding RNAs
(ncRNAs, such as tRNAs, rRNAs, snoRNAs, snRNAs, etc.) were
firstly filtered. The remaining sequencing reads were then
analyzed by aligning to known human miRNA precursor
sequences from the miRBase database (Release 16.0, http://
www.mirbase.org/) [45] using Bowtie 0.12.7 [46]. Only one
mismatch was allowed without considering adaptor sequences.
Due to employed a two-base encoding technology, only one single
mismatch always was a sequencing error and should be corrected
according to reference nucleotide. If the position of the mismatch
was located at 39 end, and followed colorspace (in fact, it is the first
colorspace of adaptor sequence) was also a mismatch, it should be
a non-template additional nucleotide or 39 modification event.
Based on these, 39 nucleotide additions of miRNAs were identified
and collected.
Assessment of differentially expressed miRNA profile
Due to multiple isomiRs were yielded from a single miRNA
locus, miRNA profile was assessed by using sequence count of the
most abundant isomiR and sum of all isomiRs sequence counts,
respectively. Simultaneously, we also estimated differentially
expressed miRNAs based on the different methods. Differentially
expressed isomiRs with 39 non-template additional nucleotides
were also estimated and selected between pairwise samples.
Furthermore, isomiR spectrum and expression distribution pattern
from a given locus were analyzed across the three samples.
Gene Ontology enrichment analysis
We selected those differentially expressed isomiRs with 39
additions and collected their experimentally validated target sites
from the miRTarBase database [43] if they had the same ‘‘seed
sequences’’ with their canonical miRNA sequences in the
miRBase database. These genes were then queried for Gene
Ontology Enrichments using CapitalBioH Molecule Annotation
System V4.0.
Supporting Information
Figure S1 Length distribution of miRNAs through analyzing
deep sequencing datasets.
(TIF)
Figure S2 Frequencies of heterogeneity of 59 and 39
ends. The frequency is estimated based on type of isomiRs
without involved isomiRs with 39 additions. 39 isomiRs are quite
prevalent than 59 isomiRs across the three samples.
(TIF)
Figure S3 Distribution patterns of miRNAs and type of
isomiRs. Expression distributions of miRNAs are assessed from
lower to higher expression levels based on sum of all isomiR
sequence counts, while their corresponding types of isomiRs show
chaos distributions. No strict correlation is found between
expression level of miRNA and its type of isomiRs. All of these
miRNAs are abundantly expressed in corresponding sample
(sequence count of the most abundant isomiR is over 999). Type
of isomiRs is assessed based on their sequence counts (.99). To
avoid great expression difference among miRNAs, some miRNAs
with quite high expression levels are removed.
(TIF)
Figure S4 Percentage distributions of 39 additions
across different samples. Here we only consider those
isomiRs that sequence counts are over 99. Percentage of 39
additions based on (A) all type of isomiRs; (B) sequence counts of
all isomiRs; (C) type of all isomiRs; (D) sequence counts of all
isomiRs; (E) type of isomiRs with 39 additions; (F) sequence counts
of isomiRs with 39 additions.
(TIF)
Figure S5 The 39 non-template double additional nucleotides
and their percentage across different samples.
(TIF)
Table S1 The number of total sequencing reads and reads that
match to known miRNAs.
(DOC)
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their experimental validated gene targets from the miRTarBase
database.
(DOC)
Table S3 Sequence count of miRNA (based on the most
abundant isomiR) and its type of isomiRs across different
samples.
(DOC)
Table S4 The most abundant isomiR sequence varies among
different samples.
(DOC)
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